Supernus Pharmaceuticals, Inc.
$2.45B- Market cap
- $2.53B
- Debt
- +$43.80M
- Cash
- −$128.45M
Capital structure 98% equity / 2% debt · EV / Revenue 3.40x · EV / EBITDA 50.52x
Quick read
Fair value engine
Each company valued on the other's multiple, then compared with the market price.
SUPN · current priceP/S 3.52x
$43.53Latest market snapshot
Implied fair value · at SBGI's multiple
$3.8591.2% below market
12.37 SUPN revenue / share×0.31x SBGI P/S=$3.85
Market $43.53Implied $3.85
SBGI · current priceP/S 0.31x
$13.81Latest market snapshot
Implied fair value · at SUPN's multiple
$161.361,068.4% above market
45.85 SBGI revenue / share×3.52x SUPN P/S=$161.36
Market $13.81Implied $161.36